Pregnancy Point of Care Testing Market

Global Pregnancy Point of Care Testing Market Size, Share and Trends Analysis Report, By Type (LH Urine Test, FSH Urine Test, HCG Blood Test, and HCG Urine Test), By Distribution Channel (Pharmacies, Fertility Clinics, and Hypermarkets and Supermarkets), Forecast (2021-2027)

Published: Dec 2021 | Report Code: OMR2025225 | Category : Medical Devices | Delivery Format: /

The global pregnancy point of care testing market is expected to grow at a significant CAGR during the forecast period (2021-2027). The pregnancy point of care testing is a medical diagnostic procedure that enables the identification of the probability of pregnancy in women by estimating the level of various reproductive hormones including the follicle-stimulating hormone, luteinizing hormone, and growth hormone. It also estimates the exact day of ovulation to determine the pregnancy and fertility condition. 

The quick and accurate diagnostic result, time-efficient process, and ability to perform the test without clinical and hospital support are some major benefits associated with pregnancy point of care testing. The rising technological advancement in design and development of pregnancy point of care testing and rising adoption of pregnancy point of care testing coupled with the growing urban population is further anticipated to create new opportunities for the market. Additionally, the growing incidence of fertility and gynecological disorders along with the preference for fast and self-contained tests is projected to drive the growth of the market during the forecast period.

The global pregnancy point of care testing market includes some of the key vendors such as Abbott Laboratories, Quidel Corp., among others. To maintain a strong position in the market, these market players are adopting various strategies that include product launches, partnerships and collaborations, and mergers and acquisitions. For instance, in November 2021, SaliStick was developed by Jerusalem-based company Salignostics and uses the same saliva-based hormone detection technology found in the company’s Covid test kits. SaliStick works by detecting the pregnancy hormone ?-hCG in the saliva as early as the first day of a missed period.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape- Abbott Laboratories, Quidel Corp., among others

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Pregnancy Point of Care Testing Market Report Segmentation

By Type 

o LH Urine Test 

o FSH Urine Test

o HCG Blood Test 

o HCG Urine Test  

By Distribution Channel

o Pharmacies 

o Fertility Clinics 

o Hypermarkets and Supermarkets 

Global Pregnancy Point of Care Testing Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World